Infectious Diseases

Infectious Diseases


Hepatitis C: A Guide to Current Management

New Clinical Collection from NEJM Group!

Recommendations for universal screening and a plethora of new drugs have profoundly affected clinical practice. This collection will arm clinicians to meet the challenges ahead as we enter an era in which the hepatitis C virus can be practically eradicated in many patients and populations. For this and other Collections, visit

Medical News

Will the When-to-Start Discussion Finally End? Free

Results from the START study, released early, support offering ART to all HIV-infected people, regardless of CD4-cell count.

Drug Watch / Vaccine Watch

FDA Approves a TAF-Containing Fixed-Dose Combination for Treatment of HIV Infection

The first tenofovir alafenamide–containing combination to be approved is similar to tenofovir disoproxil–based therapy in efficacy but has more favorable effects on markers of bone and kidney health.

HIV and ID Observations Blog

Just Wondering: Quick ID Questions to Consider Free

Dr. Paul Sax asks some quick infectious diseases questions.


Guideline Watch

Management of Latent Mycobacterium tuberculosis Infection in Low-Incidence Countries

This WHO-issued document provides evidence-based guidance on whom to test and how to treat for latent tuberculosis infection in countries with low tuberculosis incidence.

Infective Endocarditis in Adults

An update to guidelines published in 2005, this new document continues to incorporate an evidence-based scoring system but now provides the evidence level for each recommendation.